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differences in hypertension among patients with
type 2 diabetes in Sweden
Marina Taloyan1,2*, Nuha Saleh-Stattin1, Sven-Erik Johansson1,3, Lars Agréus1 and Per Wändell1Abstract
Background: Hypertension is common among persons with type 2 diabetes. The aim of this study was to analyze
the association between ethnicity and hypertension prevalence after adjusting for age, sex, Hba1c, total cholesterol,
elevated triglycerides and hypertriglyceridemic waist. The study population consisted of 354 primary health care
patients diagnosed with type 2 diabetes (173 Assyrians/Syrians and 181 Swedes) residing in Södertälje, Sweden.
Unconditional logistic regression was used to analyze the data.
Results: Hypertension prevalence was higher among Swedes than Assyrians/Syrians, (77% versus 58%; p = 0.001). In
the unadjusted logistic regression model, the odds ratio for hypertension in Swedes was twice as high than that in
Assyrians/Syrians (OR = 2.44; 95% CI =1.54-3.86). In the age- and sex-adjusted model, odds ratio of hypertension was
2.25 (95% CI 1.41-3.60). After adjustments for total cholesterol was made, the odds ratio of hypertension decreased
slightly to 1.73. When elevated triglycerides and hypertriglyceridemic waist were separately introduced, the odds
ratio of hypertension was no longer significant between the ethnic groups (1.60 and 1.43 for triglycerides and
hypertriglyceridemic waist respectively). In addition, advanced age – 60–69 years old (OR = 1.80, CI 95%
1.00-3.20) and≥ 70 years old (OR = 2.88, CI 95% 1.40-5.93), elevated total cholesterol (OR = 1.48, CI 95% 1.12-1.95)
and presents of hypertriglyceridemic waist (those with high WC and high TG) were significant confounding factors
for the increased risk of hypertension independent of ethnicity.
Conclusions: The crude differences in prevalence of hypertension between the Swedes and Assyrians/Syrians in
our study population with type 2 diabetes were no longer significant when adjusting for high triglycerides levels or
the presence of hypertriglyceridemic waist.
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Type 2 diabetes is an independent risk factor for cardio-
vascular disease [1] and diabetes-related complications
[2]. Hypertension and hyperglycaemia are common in
persons with type 2 diabetes and have been shown to in-
crease the risk of cardiovascular disease [3,4]. Risk fac-
tors for developing hypertension include age, high
alcohol intake [5] and dyslipidemia [6], smoking [7],
stress [8], lifestyle [9], and family history of hypertension
[10]. High body mass index (BMI) [11] and physical* Correspondence: marina.taloyan@sll.se
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reproduction in any medium, provided the orinactivity [12] are common risk factors for developing
both hypertension and type 2 diabetes. Diabetes, hyper-
tension, elevated triglycerides and hypertriglyceridemic
waist (hyperTG waist) are all features of the metabolic
syndrome [13].
Previous studies on the relationship between migra-
tion, ethnicity, hypertension, and diabetes have reported
a variety of findings. For instance, a study from the U.S.
showed that age and BMI, possibly combined with pres-
ence of a psychiatric disorder, history of trauma, and im-
migrant status, contributed to a higher overall
prevalence of both hypertension and diabetes in immi-
grants than in native Americans [14]. By contrast, in
Sweden, hypertension was shown to be less common inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Swedes after adjusting for BMI [15].
Few studies have looked into the prevalence of hyper-
tension in immigrants with type 2 diabetes living in Swe-
den. Previous analyses of the data used in this study
showed that Swedes with type 2 diabetes had a higher
prevalence of and more twice as high odds of hyperten-
sion than had Assyrians/Syrians with type 2 diabetes.
These differences between the groups could not be
explained by differences in sociodemographic situation
[16]. Hence, the aim of this study was to analyze the as-
sociation between ethnicity and hypertension prevalence
after adjusting for age, sex, anthropometric measures
and blood lipids.
Results
The study population consisted of 354 individuals with
type 2 diabetes living in Södertälje, Southern Sweden,
173 of whom were Assyrians/Syrians and 181 were
Swedes. Men and women were equally represented in
the sample (Table 1). The Assyrians/Syrians had a mean
age of 61 years (range 32–83 years), whereas Swedes had
a mean age of 64 years (range 32–86 years). More than a
third of the Swedes (35.0%) and less than a third of the
Assyrians/Syrians (26.2%) were ≥ 70 years of age. More-
over, obesity (BMI ≥ 30) was more prevalent among
Assyrians/Syrians (57.0%) than Swedes (42.0% P= 0.038),
whereas an overweight was more prevalent among
Swedes (44.5%) than Assyrians/Syrians (30.0%). Moder-
ate self-reported alcohol consumption was higher among
Swedes (81.0%) than Assyrians/Syrians (44.5%) and more
than half of the Assyrians/Syrians (52.5%) and less than
a fifth (15%) of the Swedes reported they had never used
alcohol.
The prevalence of elevated HbA1c, elevated total chol-
esterol, and elevated triglyceride levels in the two groups
are shown in Table 1. There were no significant differ-
ences in the prevalence of either elevated HbA1c or total
cholesterol levels, nor were there any differences in use
of medication and presence of hyperTG waist, between
the Assyrians/Syrians and Swedes. However, Swedes had
a significantly higher prevalence of elevated triglycerides
(64.0%) than had Assyrian/Syrians (40.0%) and preva-
lence of hypertension was significantly higher in Swedes
(77.0%) than was in Assyrian/Syrians (58.0%).
Prevalence of hypertension by ethnicity and sex in the
two groups is shown in Table 2. We found significant
differences in alcohol consumption and elevated trigly-
cerides between Swedish and Assyrian/Syrian women.
The majority of Assyrian/Syrian women were low-level
alcohol consumers, whereas most Swedish women were
moderate alcohol consumers. Elevated triglycerides were
significantly more prevalent in Swedish than in Assyr-
ian/Syrian women. By contrast, no significant differencesin either alcohol consumption or elevated triglyceride
prevalence were found between Swedish and Assyrian/
Syrian men.
Table 3 shows the prevalence of hypertension by eth-
nicity and explanatory variables, such as age, sex, BMI,
abdominal obesity, alcohol consumption, medication,
elevated total cholesterol, elevated HbA1c, elevated tri-
glycerides and presence of hyperTG waist. Mean systolic
blood pressure reading was significantly higher in
Swedes than was in Assyrians/Syrians. In addition,
Swedes with elevated total cholesterol had an overall
higher prevalence of hypertension than had Assyrian/
Syrians with elevated total cholesterol.
Logistic regression
In the unadjusted logistic regression model, the OR of
hypertension among Swedes was more than twice as
high than in Assyrians/Syrians (OR= 2.44; 95% CI
=1.54-3.86). In the logistic regression models applied to
estimate the effect of statistically significant factors are
shown in Table 4. Abdominal obesity, alcohol consump-
tion, BMI, use of medication, and HbA1c were shown to
be not statistically significant and were thus excluded.
Models 1–3 were generated after adjustments for age,
sex, and elevated total cholesterol were made. Models 3
and 4 were generated stepwise by separate analyses with
elevated triglycerides and presence of hyperTG waist.
Ethnic differences in the prevalence of hypertension
were not significant. Significant confounders were age,
elevated total cholesterol levels and presence of
hyperTG waist (Model 4). Although the variable elevated
triglycerides was not significant, it could explain ethnic
differences in prevalence of hypertension. In addition,
advanced age – 60–69 years old (OR= 1.80, CI 95%
1.00-3.20) and ≥ 70 years old (OR= 2.88, CI 95% 1.40-
5.93), elevated total cholesterol (OR= 1.48, CI 95% 1.12-
1.95) and presents of hypertriglyceridemic waist (those
with high WC and high TG) were significant confound-
ing factors for the increased risk of hypertension inde-
pendent of ethnicity.
Discussion
Summary of results and comparison with results from
other studies
The main finding of this study was that ethnic differ-
ences in hypertension prevalence between Swedes and
Assyrians/Syrians were no longer significant when
adjustments for both elevated level of triglycerides and
hyperTG waist were made. Furthermore, regardless of
ethnicity, those with high WC and high TG had approxi-
mately three times higher odds of hypertension than
those with low WC and low TG.
Our finding that Swedes had a higher prevalence of
hypertension than Assyrians/Syrians had is not consistent
Table 1 Distribution (%) of background variables and anthropometric data (means; standard deviations) on Assyrian/
Syrians and Swedes (n = 354)
Variables Assyrians/Syrians n = 173 Swedes n = 181 P value
Total 48.9 51.1
Sex
Women 48.5 44.2 0.411
Men 51.5 55.8
Age (years)
32–59 46.5 32.6 0.026
60–69 27.3 32.6
≥70 26.2 34.8
Body mass index 33 (20.2) 30 (6.0) 0.059
BMI (kg/m2)
Normal (<25) 13.0 13.5 0.038
Overweight (25.0–29.9) 30.0 44.5
Obese (≥30) 57.0 42.0
Abdominal obesity 106.1 (12.1) 106.3 (13.8) 0.877
Women (>88 cm) 62.0 52.0 0.205
Men (102 cm) 38.0 48.0 0.447
Alcohol consumption
High 3.0 4.0 0.000*
Moderate 44.5 81.0
Low 52.5 15.0
Medication (yes) 78.1 78.6 0.912
Elevated total cholesterol (≥4.5 mmol/L) 59.0 65.0 0.359
Elevated triglycerides (≥1.7 mmol/L) 40.0 64.0 0.000
Elevated HbA1c (>6%) 49.7 40.6 0.088
Hypertension 58.0 77.0 0.001
HyperTG waist†
Low WC+ low TG 16.3 12.2 0.422
Low WC+high TG 9.9 14.9
High WC+ low TG 18.6 16.0
High WC+high TG 55.2 56.9
*Bold-faced numbers are statistically significant and corrected for multiple statistical testing (<=0.005).
† Low WC=♂≤ 102 ♀≤ 88; Low TG=< 2.0; High WC=♂ >102 ♀ >88 WC; High TG=≥ 2.0.
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showed an association between acculturation to Western
society and high blood pressure. The authors of this meta-
analysis concluded that acculturation to Western society
was associated with increased blood pressure due to dis-
tress caused by cultural changes, independent of BMI or
elevated total cholesterol [17]. However, a Swedish study
of non-European immigrants showed a low risk of hyper-
tension when adjustments for socio-economic, lifestyle
and anthropometric factors were made [16].
In this study, we compared the prevalence of normal
blood pressure among our participants with that of all
persons included in the Swedish National DiabetesRegister (NDR), a national quality-of-care register that
covers almost 60 percent of all people in Sweden with
diabetes and contains no information on ethnicity. NDR
data from 2008 [18] indicate that 35.0% of the popula-
tion in the register had normal blood pressure (≤130/
80 mmHg). According to the data in this study, almost a
fourth of the Swedes (23.3%) and nearly half the Assyr-
ians/Syrians (42.1%) had normal blood pressure which
suggests that the Swedes in our study population had a
higher prevalence of hypertension (77%) than the na-
tional average (65%), whereas Assyrians/Syrians have a
lower prevalence of hypertension (58%) than the na-
tional average.
Table 2 Prevalence (%) of hypertension and explanatory variables by ethnicity and sex
Women P value Men P value
Assyrian/Syrian Swedes Assyrian/Syrian Swedes
n = 89 n=101 n=84 n=80
Variables
Totals 56.1 80.0 0.007* 59.1 74.0 0.065
Body mass index
Normal <25 12.0 10.0 0.050 14.0 16.0 0.475
Overweight 25.0–29.9 23.0 44.0 37.0 45.0
Obese ≥30 65.0 46.0 49.0 39.0
Abdominal obesity
Women (>88 cm) 93.5 88.5 0.383
Men (102 cm) 53.7 62.8 0.295
Alcohol consumption
High 0.0 0.0 <0.0001 6.0 7.2 0.271
Moderate 18.0 84.0 69.0 78.3
Low 82.0 16.0 25.0 14.5
Medication (yes) 81.1 82.3 0.876 77.8 75.9 0.828
Elevated total cholesterol
(≥4.5 mmol/L) 65.2 70.0 0.582 53.5 61.0 0.380
Elevated HbA1c (>6%) 50.0 56.0 0.522 46.5 33.3 0.112
Elevated triglycerides
(≥1.7 mmol/L) 41.0 74.0 <0.0001 38.0 56.5 0.028*
HyperTG waist†
Low WC+ low TG 34.8 21.0 0.094 5.0 2.1 0.091
Low WC+high TG 10.9 16.1 2.5 8.5
High WC+ low TG 43.4 35.5 57.5 34.1
High WC+high TG 10.9 27.4 35.0 55.3
* Statistically non-significant after correction for multiple statistical testing (<=0.007).
†Low WC=♂≤ 102 ♀≤ 88; Low TG=< 2.0; High WC=♂ >102 ♀ >88 WC; High TG=≥ 2.0.
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levels and, thus, could not estimate the prevalence of
metabolic syndrome among our participants. For that,
we used the presence of hyperTG waist as a proxy for
metabolic syndrome. However, we did not use the estab-
lished definition of hyperTG waist for this population
sample, i.e. waist circumference (WC) of >90 cm in men
and >85 cm in women, as all men had a waist circumfer-
ence larger than that, why we used another cut-off value
(≤102) instead. As expected, we found that presence of
hyperTG waist, namely the fourth group of hyperTG –
high WC and high TG, comprised a significant explana-
tory factor for the prevalence of hypertension both
among Assyrians/Syrians and Swedes. Given that dia-
betes, hypertension, elevated triglycerides and hyper-
triglyceridemi have all been shown to be features of
metabolic syndrome, this finding was not unexpected.
Another potentially important factor for hypertensionprevalence was high alcohol intake, but very few of the
participants in this study were high-level alcohol consu-
mers, thus, the association between high alcohol intake
and hypertension prevalence could not to be assessed.
Besides, since this study included only individuals with
type 2 diabetes, a putative association between alcohol
intake and hypertension prevalence may be different
than that among individuals without diabetes.
In this study we showed that Swedes had a higher
prevalence of elevated triglycerides than had Assyrians/
Syrians, which is not consistent with findings from a
Swedish study of 60-year-old persons residing in Stock-
holm County [19]. In that study, non-European immi-
grants had higher ORs of high triglyceride levels and low
HDL-cholesterol levels than did Swedish-born persons.
However, our study included persons with type 2 dia-
betes, whereas the previous study included non-diabetic
persons. Moreover, we only had access to data on total
Table 3 Prevalence (%) of hypertension (systolic ≥130 mm Hg or diastolic≥ 80 mm Hg) and means with standard
deviations (SD) blood pressure in Assyrians/Syrians and Swedes by ethnicity and explanatory variables and test of
differences in distribution by ethnicity (chi2)
Variables Prevalence of hypertension
Swedish-born Assyrian/Syrian-born P value
Totals 77.0 58.0 0.001*
Age
32–59 76.0 46.4 0.004
60–69 66.0 67.0 0.939
≥70 88.0 72.4 0.103
Sex
Women 80.0 56.1 0.007
Men 74.0 60.0 0.065
Body mass index
Normal <25 75.0 50.0 0.134
Overweight 25.0–29.9 74.0 51.2 0.025
Obese≥ 30 80.0 63.0 0.039
Abdominal obesity
Women (>88) 80.0 56.5 0.011
Men (>102) 79.0 60.5 0.079
Alcohol consumption
High 100.0 75.0 0.236
Moderate 76.0 57.4 0.014
Low 72.2 57.4 0.237
Medication (yes) 79.3 79.6 0.960
Elevated total cholesterol
(≥4.5 mmol/L) 83.1 62.0 0.003
Elevated HbA1c
(>6%) 80.4 67.0 0.099
Elevated triglycerides
(≥1.7 mmol/L) 80.3 70.4 0.192
Systolic/diastolic Mean (SD) 142.4 (19.0) / 82.0 (13.3) 135.1 (17.0)/78.6 (11.4) 0.0002/0.025
HyperTG waist†
Low WC+ low TG 16.2 (24) 21.2 (31) 0.001
Low WC+high TG 11.5 (17) 6.2 (9)
High WC+ low TG 37.2 (55) 54.1 (79)
High WC+high TG 35.1 (52) 18.5 (27)
*Bold-faced numbers are statistically significant and corrected for multiple statistical testing (<=0.005).
†Low WC=♂≤ 102 ♀≤ 88; Low TG=< 2.0; High WC=♂ >102 ♀ >88 WC; High TG=≥ 2.0.
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ORs of low HDL- or high LDL-cholesterol levels.
Studies have indicated that lifestyle choices such as exer-
cise and low-sodium high-potassium diet can lead to
decreased blood pressure [20] and increased carbohydrate
intake was shown to be associated with elevated triglycer-
ide levels [21]. However, we did not have access to data on
dietary habits of the participants in in this study.Strengths and limitations of the study
A major strength of this study was its use of data from
an ethnically homogeneous group, who identified them-
selves on an ethnic rather than a non-ethnic basis, i.e. as
Assyrians/Syrians and not as nationals of their country
or region of birth (Turkey, Lebanon, Middle East, etc).
Despite the small sample size, the study population was
considered representative of Assyrians/Syrians of four
Table 4 Odds ratios with 95% confidence intervals of hypertension in Assyrians/Syrians and Swedes with type 2
diabetes in four logistic regression models
Variable Crude OR Model 1: (age, sex) Model 2: (+chol) Model 3: (+chol, +trig) Model 4: (+chol, +hyperTG)
Assyrians/Syrians Reference Reference Reference Reference Reference
Swedes 2.44* 2.25 1.73 1.60 1.43
1.54-3.86 1.41-3.60 1.05-2.84 0.95-2.70 0.84-2.44
Age groups (years)
32–59 Reference Reference Reference Reference
60–69 1.61 1.80 1.88 1.80
0.95-2.72 1.03-3.12 1.05-3.33 1.00-3.20
≥70 2.53 2.40 3.00 2.88
1.40-4.80 1.21-4.64 1.45-6.10 1.40-5.93
Sex
Men Reference Reference Reference Reference
Women 1.20 1.43 1.20 1.42
0.75-1.90 0.87-2.32 0.70-2.00 0.79-2.60
Elevated total cholesterol
No Reference Reference Reference







Low WC+ low TG Reference
Low WC+high TG 2.50
0.82-7.61
High WC+ low TG 1.30
0.62-2.70
High WC+high TG 2.83
1.20-6.71
* Bold-faced numbers are statistically significant.
Abdominal obesity, alcohol consumption, medication and HbA1c were tested but found to be non-significant and therefore are not shown in the table.
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cruiting participants from the same primary health care
centers eliminated the possibility that factors such as en-
vironment and neighborhood, which have been shown
to be significant confounders for the prevalence of hy-
pertension, could impact on the results of the analyses.
Although the findings of this study could not be general-
ized to all Assyrians/Syrians and Swedes with diabetes in
Sweden, they may offer an avenue for future epidemio-
logical studies.
The major limitations of the current study were the
cross-sectional design, which precluded causal associa-
tions, and the small sample size. Due to the lack of data
on HDL-cholesterol levels and medication prescribed totreat hypertension, we were not able to confirm presence
of the metabolic syndrome. In addition, lack of informa-
tion on whether hypertension was treated or not, meant
that we could not draw any conclusions based on our
results. To counteract this shortcoming, blood pressure
measurements were performed.
Conclusions
In conclusion, we found that the Swedes in our study
population had a higher prevalence of hypertension than
had the Assyrians/Syrians in the same population. The
crude differences in prevalence of hypertension between
the Swedes and Assyrians/Syrians in our study popu-
lation with type 2 diabetes were no longer significant
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ence of hypertriglyceridemic waist.
Methods
Setting and participants
This cross-sectional study was based on a health survey
conducted at four primary health care centers in Söder-
tälje from 2006 to 2008 as the same study previously
published in BMC Public Health [22]. One specific
group, Assyrians/Syrians, was chosen for study because
they are concentrated in great numbers in a single urban
area located just south of Stockholm, the town of Söder-
tälje, in which first and second generation immigrants
(not all Assyrians/Syrians) constitute 44.0% of the total
population according to statistics of Stockholm County.
The registers over diabetes patients (already diagnosed
by GP) at each primary health care centers were used.
Data sources
Information on ethnicity, age, sex, and alcohol consump-
tion was gathered during face-to-face interviews. Blood
pressure and anthropometric measurements, including
height, weight, and waist circumference, were made after
the interview by the first author or participating GPs.
Medical information and laboratory data were gathered
from patient records after obtaining verbal informed
consent from all participants. Patients with diagnosed
type 2 diabetes were included in the survey.
Explanatory variables
Ethnicity was defined as Swedish or Assyrian/Syrian. At
the interview, all participants who had been provisionally
identified as Swedes were asked “Are you Swedish?”
Those who answered “No” were asked additional ques-
tions about country of birth and ethnic identity, and if
they did not identify themselves as Assyrians/Syrians,
were excluded from the study. Participants who were
provisionally identified as Assyrians/Syrians were asked
about country of birth and ethnic identity.
Age was stratified into three groups: 32–59, 60–69,
and ≥70 years.
Anthropometric measurements
Body mass index (BMI) was calculated as weight divided
by height squared (kg/m2). BMI < 25 was considered
normal; BMI 25.0–29.9, overweight, and BMI≥ 30,
obese.
Abdominal obesity was defined as a waist circumfer-
ence of ≥ 102 cm in men and ≥ 88 cm in women. Both
BMI and Abdominal obesity were defined on the basis of
established guidelines for adults [23].
Hypertriglyceridemic waist (HyperTG waist) is a sug-
gested as a screening tool for identification of metabolic
syndrome and based on several studies [24-26]. Wechoose to use HyperTG waist because of lack of data on
HDL-cholesterol. Originally, a high waist circumference
(WC) was defined by >90 cm in men and >85 cm in
women, and a high triglycerides (TG) ≥2.0 mmol/l.
However, as in our study no men showed a WC ≤90 cm
we decided to use other cut-off values, i.e. >102 cm in
men and 88 cm in women, often used in different defini-
tions of the metabolic syndrome [13]. HyperTG waist
was categorized into four groups: (1) low WC and low
TG; (2) low WC and high TG; (3) high WC and low TG;
(4) high WC and high TG.
Alcohol consumption was based on two questions on
frequencies and quantities of drinking
– −Do you drink alcohol? Response alternatives were
“often,” “sometimes,” and “never.”
– −Do you drink at least half a bottle of spirits or a
couple of bottles of wine per week? Response
alternatives were “often,” “sometimes,” and “never.”
Participants who answered “never” in response to
both questions were defined as low consumers.
Those who responded that they often or sometimes
drank alcohol and often drank at least half a bottle
of spirits or a couple of bottles of wine per week
were defined as high consumers. The rest were
defined as moderate consumers. Categorization of
alcohol consumption was based on validation done
by Theobald [27].
Medication was based on response of taking drugs for
normalization of HbA1c level or dietary treatment. We
lack the information on medication against hypertension.
Total cholesterol was divided into two groups: normal
(<4.5 mmol/L) and elevated (≥4.5 mmol/L).
HbA1c was divided into two groups: normal (≤6.0%)
and elevated (>6.0%) using the Swedish mono-S method
[28]. The mono-S method is the standard method in
Sweden for defining normal and elevated HbA1c.
Values ≥ 6% are considered elevated, which differs from
the Diabetes Control and Complications Trial (DCCT)
standard of >7%, which is the world standard [28].
Triglycerides were divided into normal (<1.7 mmol/L)
and elevated (≥1.7 mmol/L).
All medical values were taken from patient journal
records which were based on biochemical analyses per-
formed at the same place at the laboratory at the Karo-
linska Universitet. According to the laboratory was HbA1c
measured, after a chromatographic separation, through
detection of absorbance at 415 nm by ”The Variant II
Turbo Clinical Data Management (CDM) Software”,
delivered by Bio-Rad, Variant II Turbo HbA1c Kit – 2.0
(Cat. No.270-2455EX). Total cholesterol was measured
through detection of a colored quinoeimin product, after
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then was oxidized to cholesten-3-one and hydrogen
peroxide, the latter reacting with 4-aminantipyrin and
phenol to the colored quinoeimin product, by DXC800
(2020) from Beckman-Coulter. Triglycerides were hydro-
lyzed to glycerol and free fatty acids, glycerol was reacted
into glycerol-3-phosphate, oxidized into hydrogen per-
oxide, coupling 3,5-dichloro-2-hydroxybenzenesulfonic acid
(DHBS) with 4-aminoantipyrine into a red complex which
was measured, by DXC800 (2020) from Beckman-Coulter.Outcome variable
Hypertension was defined on the basis of the International
Diabetes Federations guidelines for individuals with type 2
diabetes [29]. Blood pressure was measured once in the
right arm in the sitting or lying position following 5 min-
utes of rest after the interview. The instrument used was a
Boso Medicus Prestige Digital Sphygmomanometer; two
different adult cuff sizes were used. Systolic blood pressure
was dichotomized as normal (<130 mmHg) and high (≥
130 mmHg). Diastolic blood pressure was divided into
normal (<80 mmHg) and high (≥80 mmHg). If either the
systolic blood pressure was≥130 mmHg and/or the dia-
stolic blood pressure was≥ 80 mmHg, the patient was
considered to be hypertensive.Statistical analyses
The description of the distribution of a number of the
background variables included mean ± standard devi-
ation. The prevalence, in percentage, of the dependent
variable was estimated separately for Assyrians/Syrians
and Swedes using the statistical software program Stata
v.9 [30]. The test of level of significance in the prev-
alence of hypertension and all explanatory variables
were performed by using Pearson’s chi-square test. Sta-
tistical significance was established at P < 0.05 (two-tailed
P values). Unconditional logistic regression was used to
calculate the ORs and 95% confidence intervals (95%
CIs) to analyze the association between hypertension
and explanatory variables. We used different models with
different explanatory variables. In the second model, be-
side age and sex in addition to ethnicity, we tested ele-
vated total cholesterol. In the third model elevated
triglycerides and in the fourth model hyperTG waist was
separately introduced. All medical values total choles-
terol and triglycerides were included into logistic re-
gression as continuous variables. High BMI, abdominal
obesity, alcohol consumption, medication, and HbA1c
did not reach significance and were excluded. The fit
of the models was assessed by the Hosmer-Lemeshow
goodness-of-fit test. This test is a Chi-square statistic
from g*2 table (with g-2 degrees of freedom) of observed
and expected frequencies [31]. The final models inlogistic regression analyses were considered acceptable
if p > 0.05, and all models met this demand [31].
Ethical considerations
The study was approved by the Regional Ethical Com-
mittee of Karolinska Institutet (reference no. 2006/4:8,
2006-09-27). All participants received information about
the study in written and verbal form. Participants pro-
vided verbal informed consent prior to the onset of par-
ticipation and again before information was gathered
from medical records.
Abbreviations
BMI: Body mass index; CI: Confidence Interval; GP: General practitioner;
HbA1c: haemoglobin A1c; HyperTG waist: Hypertriglyceridemic waist;
NDR: National Diabetes Register; OR: Odds ratio; PHCC: Primary health care
center; TG: Triglycerides; WC: Waist circumference.
Competing interests
The authors have not declared any conflicts of interest.
Authors’ contributions
MT conceived the idea for the survey. MT, NSS, SEJ, LA and PW designed the
study. MT and PW performed the statistical analysis. MT drafted the
manuscript. NSS, SEJ, LA and PW revised the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
We would like to thank the GPs at the four PHCC for help with gathering
data. Also Scientific Editors Kimberly L. Kane and Stella Papadopoulou of the
Center for Family and Community Medicine for linguistic revision of the
manuscript and valuable comments on the text. We would like to thank the
staff at Karolinska University laboratory for contributing valuable knowledge
on biochemical analysis techniques.
Author details
1Karolinska Institutet, Centre for Family and Community Medicine, Alfred
Nobels allé 12, Huddinge, SE 141 83, Sweden. 2Stress Research Institute,
Stockholm University, Stockholm, Sweden. 3Centre for Primary Health Care
Research, Region Skåne, Lund University, Malmö, UMAS 205 02, Sweden.
Received: 23 December 2011 Accepted: 21 August 2012
Published: 31 August 2012
References
1. Selvin E, et al: Meta-analysis: glycosylated hemoglobin and cardiovascular
disease in diabetes mellitus. Ann Intern Med 2004, 141(6):421–431.
2. Deshpande AD, Harris-Hayes M, Schootman M: Epidemiology of diabetes
and diabetes-related complications. Phys Ther 2008, 88(11):1254–1264.
3. Stratton IM, et al: Additive effects of glycaemia and blood pressure
exposure on risk of complications in type 2 diabetes: a prospective
observational study (UKPDS 75). Diabetologia 2006, 49(8):1761–1769.
4. Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of
atherosclerotic disease. New perspectives based on the Framingham study.
Ann Intern Med 1979, 90(1):85–91.
5. Carlsson AC, et al: Risk factors associated with newly diagnosed high
blood pressure in men and women. Am J Hypertens 2008, 21(7):771–777.
6. Yao XG, et al: The prevalence of hypertension, obesity and dyslipidemia
in individuals of over 30 years of age belonging to minorities from the
pasture area of Xinjiang. BMC Publ Health 2010, 10:91.
7. Thuy AB, et al: The association between smoking and hypertension in a
population-based sample of Vietnamese men. J Hypertens 2010,
28(2):245–250.
8. Hackam DG, et al: The 2010 Canadian Hypertension Education Program
recommendations for the management of hypertension: part 2 - therapy.
Can J Cardiol 2010, 26(5):249–258.
9. Banda JA, et al: Protective Health Factors and Incident Hypertension in
Men. Am J Hypertens 2010, 23(6):599–605.
Taloyan et al. BMC Research Notes 2012, 5:474 Page 9 of 9
http://www.biomedcentral.com/1756-0500/5/47410. Ehret GB: Genome-wide association studies: contribution of genomics to
understanding blood pressure and essential hypertension. Curr Hypertens
Rep 2010, 12(1):17–25.
11. Forman JP, Stampfer MJ, Curhan GC: Diet and lifestyle risk factors
associated with incident hypertension in women. Jama 2009,
302(4):401–411.
12. Al-Tannir M, et al: Prevalence of physical activity among Lebanese adults:
a cross-sectional study. J Phys Act Health 2009, 6(3):315–320.
13. Carlsson AC, et al: Is a unified definition of metabolic syndrome needed?
Comparison of three definitions of metabolic syndrome in 60-year-old
men and women. Metab Syndr Relat Disord 2009, 7(3):231–241.
14. Kinzie JD, et al: High prevalence rates of diabetes and hypertension
among refugee psychiatric patients. J Nerv Ment Dis 2008, 196(2):108–112.
15. Carlsson AC, et al: Prevalence of hypertension in immigrants and
Swedish-born individuals, a cross-sectional study of 60-year-old men
and women in Sweden. J Hypertens 2008, 26(12):2295–2302.
16. Taloyan M, et al: Cardiovascular risk factors in Assyrians/Syrians and
native Swedes with type 2 diabetes: a population-based epidemiological
study. Cardiovasc Diabetol 2009, 8:59.
17. Steffen PR, et al: Acculturation to Western society as a risk factor for high
blood pressure: a meta-analytic review. Psychosomatic medicine 2006,
68(3):386–397.
18. Diabetesregister., N: Diabetolog Nytt. In Year report. 3rd edition. Edited by
Attvall S. Göteborg: Swedish Society for Diabetology; 2008:21.
19. Wandell PE, et al: Prevalence of blood lipid disturbances in Swedish and
foreign-born 60-year-old men and women in Stockholm. Nutr Metab
Cardiovasc Dis: Sweden; 2009.
20. Moore TJ, et al: DASH (Dietary Approaches to Stop Hypertension) diet is
effective treatment for stage 1 isolated systolic hypertension.
Hypertension 2001, 38(2):155–158.
21. Yuan G, Al-Shali KZ, Hegele RA: Hypertriglyceridemia: its etiology, effects
and treatment. Cmaj 2007, 176(8):1113–1120.
22. Taloyan M, et al: Ethnic differences in dissatisfaction with sexual life in
patients with type 2 diabetes in a Swedish town. BMC Publ Health 2010,
10:536.
23. Alberti KG, et al: Harmonizing the metabolic syndrome: a joint interim
statement of the International Diabetes Federation Task Force on
Epidemiology and Prevention; National Heart, Lung, and Blood Institute;
American Heart Association; World Heart Federation; International
Atherosclerosis Society; and International Association for the Study of
Obesity. Circulation 2009, 120(16):1640–1645.
24. Lemieux I, et al: Hypertriglyceridemic waist: A marker of the atherogenic
metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense
LDL) in men? Circulation 2000, 102(2):179–184.
25. Blackburn P, et al: The hypertriglyceridemic waist phenotype versus the
National Cholesterol Education Program-Adult Treatment Panel III and
International Diabetes Federation clinical criteria to identify high-risk
men with an altered cardiometabolic risk profile. Metabolism 2009,
58(8):1123–1130.
26. Sam S, et al: Hypertriglyceridemic waist phenotype predicts increased
visceral fat in subjects with type 2 diabetes. Diabetes Care 2009,
32(10):1916–1920.
27. Theobald H, et al: Validity of two questions on alcohol use in a health
survey questionnaire. Scand J Public Health 1999, 27(1):73–77.
28. Eckerbom S, Bergqvist Y, Jeppsson JO: Improved method for analysis of
glycated haemoglobin by ion exchange chromatography. Ann Clin
Biochem 1994, 31(Pt 4):355–360.
29. Mancia G, et al: Reappraisal of European guidelines on hypertension
management: a European Society of Hypertension Task Force document.
Blood Press 2009, 18(6):308–347.
30. StataCorp: Stata Statistical Software: Release 9.2. College station. TX: Stata
Corporation; 2007.
31. Hosmer DLS: Applied Logistic Regression. 2nd edition. New York: John
Wiley&Sous Inc; 2002.
doi:10.1186/1756-0500-5-474
Cite this article as: Taloyan et al.: Hypertriglyceridemic waist may
explain ethnic differences in hypertension among patients with type 2
diabetes in Sweden. BMC Research Notes 2012 5:474.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
